Filing metadata

Accession number
0001127602-23-023568
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Sep 01, 2023
Reporting period
Aug 31, 2023
Description
Insider transaction

Explore SEC Filings Hub